PowderJect plans £35 million flotation
This article was originally published in Clinica
Executive Summary
PowderJect Pharmaceuticals (UK) hopes to raise up to £35 million ($57 million) in a flotation scheduled for early June. The planned stock exchange listing would value the company at more than £100 million. A prospectus is due to be published in late May.